SLSara Lorio

Sara Lorio

*This is an algorithmically generated author record based on publicly available information.

Sara Lorio has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Multiparametric mapping in post-mortem perinatal MRI: a feasibility study

    by Amy R McDowell, Susan C Shelmerdine, Sara Lorio, Wendy Norman, Rod Jones, David W Carmichael, Owen J Arthurs

    Objectives: To demonstrate feasibility of a 3 T multiparametric mapping (MPM) quantitative pipeline for perinatal post-mortem MR (PMMR) imaging. Methods: Whole body quantitative PMMR imaging was acquired in four cases, mean gestational age 34 weeks, range (29–38 weeks) on a 3 T Siemens Prisma scanner. A multicontrast protocol yielded proton density, T1 and magnetic transfer (MT) weighted multi-echo images obtained from variable flip angle (FA) 3D fast low angle single-shot (FLASH) acquisitions, radiofrequency transmit field map and one B0 field map alongside four MT weighted acquisitions with saturation pulses of 180, 220, 260 and 300 degrees were acquired, all at 1 mm isotropic resolution. Results: Whole body MPM was achievable in all four foetuses, with R1, R2*, PD and MT maps reconstructed from a single protocol. Multiparametric maps were of high quality and show good tissue contrast, especially the MT maps. Conclusion: MPM is a feasible technique in a perinatal post-mortem setting, which may allow quantification of post-mortem change, prior to being evaluated in a clinical setting. Advances in knowledge: We have shown that the MPM sequence is feasible in PMMR imaging and shown the potential of MT imaging in this setting.


  • Open Access

    The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease

    by Sara Lorio, Fabio Sambataro, Alessandro Bertolino, Bogdan Draganski, Juergen Dukart

    There is an increasing interest in identifying non-invasive biomarkers of disease severity and prognosis in idiopathic Parkinson’s disease (PD). Dopamine-transporter SPECT (DAT-SPECT), diffusion tensor imaging (DTI), and structural magnetic resonance imaging (sMRI) provide unique information about the brain’s neurotransmitter and microstructural properties. In this study, we evaluate the relative and combined capability of these imaging modalities to predict symptom severity and clinical progression in de novo PD patients. To this end, we used MRI, SPECT, and clinical data of de novo drug-naïve PD patients (n = 205, mean age 61 ± 10) and age-, sex-matched healthy controls (n = 105, mean age 58 ± 12) acquired at baseline. Moreover, we employed clinical data acquired at 1 year follow-up for PD patients with or without L-Dopa treatment in order to predict the progression symptoms severity. Voxel-based group comparisons and covariance analyses were applied to characterize baseline disease-related alterations for DAT-SPECT, DTI, and sMRI. Cortical and subcortical alterations in de novo PD patients were found in all evaluated imaging modalities, in line with previously reported midbrain-striato-cortical network alterations. The combination of these imaging alterations was reliably linked to clinical severity and disease progression at 1 year follow-up in this patient population, providing evidence for the potential use of these modalities as imaging biomarkers for disease severity and prognosis that can be integrated into clinical trials.


  • Open Access

    Flexible proton density (PD) mapping using multi-contrast variable flip angle (VFA) data

    by Sara Lorio, Tim M. Tierney, Amy McDowell, Owen J. Arthurs, Antoine Lutti, Nikolaus Weiskopf, David W. Carmichael


  • Open Access

    Towards in vivo focal cortical dysplasia phenotyping using quantitative MRI

    by Sophie Adler, Sara Lorio, Thomas S. Jacques, Barbora Benova, Roxana Gunny, J. Helen Cross, Torsten Baldeweg, David W. Carmichael